Dermatologic infections in cancer patients treated with EGFRI therapy
Thursday, December 10, 2009 - 14:14
in Health & Medicine
Patients who experience dermatologic toxic effects from epidermal growth factor receptor inhibitors (EGFRIs) have a high prevalence of skin and nail infections, according to a new study.